Global Automation in Biopharmaceutical Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Automation in Biopharmaceutical Revenue
• 1.4 Market by Type
  • 1.4.1 Global Automation in Biopharmaceutical Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Clinical Stage Automation
  • 1.4.3 Drug Discovery Stage Automation
• 1.5 Market by Application
  • 1.5.1 Global Automation in Biopharmaceutical Market Share by Application: 2020 VS 2026
  • 1.5.2 Research and Development
  • 1.5.3 Clinical
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Automation in Biopharmaceutical Market Perspective (2015-2026)
• 2.2 Global Automation in Biopharmaceutical Growth Trends by Regions
  • 2.2.1 Automation in Biopharmaceutical Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Automation in Biopharmaceutical Historic Market Share by Regions (2015-2020)
  • 2.2.3 Automation in Biopharmaceutical Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Automation in Biopharmaceutical Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Automation in Biopharmaceutical Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Automation in Biopharmaceutical Players by Market Size
  • 3.1.1 Global Top Automation in Biopharmaceutical Players by Revenue (2015-2020)
  • 3.1.2 Global Automation in Biopharmaceutical Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Automation in Biopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Automation in Biopharmaceutical Market Concentration Ratio
  • 3.2.1 Global Automation in Biopharmaceutical Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Automation in Biopharmaceutical Revenue in 2019
• 3.3 Automation in Biopharmaceutical Key Players Head office and Area Served
• 3.4 Key Players Automation in Biopharmaceutical Product Solution and Service
• 3.5 Date of Enter into Automation in Biopharmaceutical Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Automation in Biopharmaceutical Historic Market Size by Type (2015-2020)
• 4.2 Global Automation in Biopharmaceutical Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Automation in Biopharmaceutical Market Size by Application (2015-2020)
• 5.2 Global Automation in Biopharmaceutical Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Automation in Biopharmaceutical Market Size (2015-2020)
• 6.2 Automation in Biopharmaceutical Key Players in North America (2019-2020)
• 6.3 North America Automation in Biopharmaceutical Market Size by Type (2015-2020)
• 6.4 North America Automation in Biopharmaceutical Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Automation in Biopharmaceutical Market Size (2015-2020)
• 7.2 Automation in Biopharmaceutical Key Players in Europe (2019-2020)
• 7.3 Europe Automation in Biopharmaceutical Market Size by Type (2015-2020)
• 7.4 Europe Automation in Biopharmaceutical Market Size by Application (2015-2020)

8 China

• 8.1 China Automation in Biopharmaceutical Market Size (2015-2020)
• 8.2 Automation in Biopharmaceutical Key Players in China (2019-2020)
• 8.3 China Automation in Biopharmaceutical Market Size by Type (2015-2020)
• 8.4 China Automation in Biopharmaceutical Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Automation in Biopharmaceutical Market Size (2015-2020)
• 9.2 Automation in Biopharmaceutical Key Players in Japan (2019-2020)
• 9.3 Japan Automation in Biopharmaceutical Market Size by Type (2015-2020)
• 9.4 Japan Automation in Biopharmaceutical Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Automation in Biopharmaceutical Market Size (2015-2020)
• 10.2 Automation in Biopharmaceutical Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Automation in Biopharmaceutical Market Size by Type (2015-2020)
• 10.4 Southeast Asia Automation in Biopharmaceutical Market Size by Application (2015-2020)

11 India

• 11.1 India Automation in Biopharmaceutical Market Size (2015-2020)
• 11.2 Automation in Biopharmaceutical Key Players in India (2019-2020)
• 11.3 India Automation in Biopharmaceutical Market Size by Type (2015-2020)
• 11.4 India Automation in Biopharmaceutical Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Automation in Biopharmaceutical Market Size (2015-2020)
• 12.2 Automation in Biopharmaceutical Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Automation in Biopharmaceutical Market Size by Type (2015-2020)
• 12.4 Central & South America Automation in Biopharmaceutical Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Danaher
  • 13.1.1 Danaher Company Details
  • 13.1.2 Danaher Business Overview
  • 13.1.3 Danaher Automation in Biopharmaceutical Introduction
  • 13.1.4 Danaher Revenue in Automation in Biopharmaceutical Business (2015-2020))
  • 13.1.5 Danaher Recent Development
• 13.2 GE
  • 13.2.1 GE Company Details
  • 13.2.2 GE Business Overview
  • 13.2.3 GE Automation in Biopharmaceutical Introduction
  • 13.2.4 GE Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.2.5 GE Recent Development
• 13.3 PerkinElmer
  • 13.3.1 PerkinElmer Company Details
  • 13.3.2 PerkinElmer Business Overview
  • 13.3.3 PerkinElmer Automation in Biopharmaceutical Introduction
  • 13.3.4 PerkinElmer Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.3.5 PerkinElmer Recent Development
• 13.4 Tecan Trading
  • 13.4.1 Tecan Trading Company Details
  • 13.4.2 Tecan Trading Business Overview
  • 13.4.3 Tecan Trading Automation in Biopharmaceutical Introduction
  • 13.4.4 Tecan Trading Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.4.5 Tecan Trading Recent Development
• 13.5 Thermo Fisher Scientific
  • 13.5.1 Thermo Fisher Scientific Company Details
  • 13.5.2 Thermo Fisher Scientific Business Overview
  • 13.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Introduction
  • 13.5.4 Thermo Fisher Scientific Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.5.5 Thermo Fisher Scientific Recent Development
• 13.6 Bruker
  • 13.6.1 Bruker Company Details
  • 13.6.2 Bruker Business Overview
  • 13.6.3 Bruker Automation in Biopharmaceutical Introduction
  • 13.6.4 Bruker Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.6.5 Bruker Recent Development
• 13.7 Peak Analysis and Automation
  • 13.7.1 Peak Analysis and Automation Company Details
  • 13.7.2 Peak Analysis and Automation Business Overview
  • 13.7.3 Peak Analysis and Automation Automation in Biopharmaceutical Introduction
  • 13.7.4 Peak Analysis and Automation Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.7.5 Peak Analysis and Automation Recent Development
• 13.8 Waters
  • 13.8.1 Waters Company Details
  • 13.8.2 Waters Business Overview
  • 13.8.3 Waters Automation in Biopharmaceutical Introduction
  • 13.8.4 Waters Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.8.5 Waters Recent Development
• 13.9 Capsugel
  • 13.9.1 Capsugel Company Details
  • 13.9.2 Capsugel Business Overview
  • 13.9.3 Capsugel Automation in Biopharmaceutical Introduction
  • 13.9.4 Capsugel Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.9.5 Capsugel Recent Development
• 13.10 RheoSense
  • 13.10.1 RheoSense Company Details
  • 13.10.2 RheoSense Business Overview
  • 13.10.3 RheoSense Automation in Biopharmaceutical Introduction
  • 13.10.4 RheoSense Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 13.10.5 RheoSense Recent Development
• 13.11 Eirechrom
  • 10.11.1 Eirechrom Company Details
  • 10.11.2 Eirechrom Business Overview
  • 10.11.3 Eirechrom Automation in Biopharmaceutical Introduction
  • 10.11.4 Eirechrom Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 10.11.5 Eirechrom Recent Development
• 13.12 BioProcess International
  • 10.12.1 BioProcess International Company Details
  • 10.12.2 BioProcess International Business Overview
  • 10.12.3 BioProcess International Automation in Biopharmaceutical Introduction
  • 10.12.4 BioProcess International Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 10.12.5 BioProcess International Recent Development
• 13.13 Novasep
  • 10.13.1 Novasep Company Details
  • 10.13.2 Novasep Business Overview
  • 10.13.3 Novasep Automation in Biopharmaceutical Introduction
  • 10.13.4 Novasep Revenue in Automation in Biopharmaceutical Business (2015-2020)
  • 10.13.5 Novasep Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer